Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of
GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) investors concerning the Company’s possible violations of the federal securities laws.
GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) investors concerning the Company’s possible violations of the federal securities laws.
If you suffered a loss on your GoodRx investments or would like to inquire about
Neueste Kommentare